Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea

Abstract Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seung-Hwa Lee, Kwang Jin Chun, Jungchan Park, Jinseob Kim, Ji Dong Sung, Rae Woong Park, Jinwook Choi, Kwangmo Yang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7df111cbe22e4160bba0f8cee6c946ce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7df111cbe22e4160bba0f8cee6c946ce
record_format dspace
spelling oai:doaj.org-article:7df111cbe22e4160bba0f8cee6c946ce2021-12-02T17:23:39ZAngiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea10.1038/s41598-021-97989-82045-2322https://doaj.org/article/7df111cbe22e4160bba0f8cee6c946ce2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97989-8https://doaj.org/toc/2045-2322Abstract Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational Medical Outcomes Partnership Common Data Model. The primary outcome was occurrence of lung cancer. A total of 207,794 patients across the 7 databases was included in the final analysis; 33,230 (16%) were prescribed ACEi and 174,564 (84%) were prescribed ARB. Crude analysis adjusted for sex and age showed higher incidence of lung cancer in the ACEi group compared to the ARB group (hazard ratio [HR], 1.46; 95% confidence rate [CI], 1.08–1.97). After propensity-score matching, 30,445 pairs were generated, and there was no difference in incidence of lung cancer between the two groups (HR, 0.93; 95% CI, 0.64–1.35). Patients prescribed ACEi showed no difference in incidence of lung cancer development compared to those using ARB. This finding provides evidence on the association between ACEi and occurrence of lung cancer.Seung-Hwa LeeKwang Jin ChunJungchan ParkJinseob KimJi Dong SungRae Woong ParkJinwook ChoiKwangmo YangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Seung-Hwa Lee
Kwang Jin Chun
Jungchan Park
Jinseob Kim
Ji Dong Sung
Rae Woong Park
Jinwook Choi
Kwangmo Yang
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
description Abstract Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational Medical Outcomes Partnership Common Data Model. The primary outcome was occurrence of lung cancer. A total of 207,794 patients across the 7 databases was included in the final analysis; 33,230 (16%) were prescribed ACEi and 174,564 (84%) were prescribed ARB. Crude analysis adjusted for sex and age showed higher incidence of lung cancer in the ACEi group compared to the ARB group (hazard ratio [HR], 1.46; 95% confidence rate [CI], 1.08–1.97). After propensity-score matching, 30,445 pairs were generated, and there was no difference in incidence of lung cancer between the two groups (HR, 0.93; 95% CI, 0.64–1.35). Patients prescribed ACEi showed no difference in incidence of lung cancer development compared to those using ARB. This finding provides evidence on the association between ACEi and occurrence of lung cancer.
format article
author Seung-Hwa Lee
Kwang Jin Chun
Jungchan Park
Jinseob Kim
Ji Dong Sung
Rae Woong Park
Jinwook Choi
Kwangmo Yang
author_facet Seung-Hwa Lee
Kwang Jin Chun
Jungchan Park
Jinseob Kim
Ji Dong Sung
Rae Woong Park
Jinwook Choi
Kwangmo Yang
author_sort Seung-Hwa Lee
title Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
title_short Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
title_full Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
title_fullStr Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
title_full_unstemmed Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
title_sort angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in korea
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7df111cbe22e4160bba0f8cee6c946ce
work_keys_str_mv AT seunghwalee angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT kwangjinchun angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT jungchanpark angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT jinseobkim angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT jidongsung angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT raewoongpark angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT jinwookchoi angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
AT kwangmoyang angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea
_version_ 1718380979250266112